Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Butazolidin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
  • G. Krook
  • Contact dermatitis
  • 1975
  • Corpus ID: 20350152
One case of fixed drug eruption caused by oxyphenbutazone with cross-sensitivity to phenylbutazone has been reported (Nayyar… Expand
Review
1955
Review
1955
  • E. Mauer
  • The New England journal of medicine
  • 1955
  • Corpus ID: 28555197
DRUGS employed in the past and at present for the relief of pain in the various forms of arthritis carry with them noxious traits… Expand
Highly Cited
1955
Highly Cited
1955
Two metabolic products of phenylbutazone have been isolated from the urine of subjects receiving the drug. One of them… Expand
Highly Cited
1954
Highly Cited
1954
Abstract 1. 1. Phenylbutazone exhibits antirheumatic effects in rheumatoid arthritis which are comparable to those shown by… Expand
Highly Cited
1953
Highly Cited
1953
1. A method is described for the estimation of phenylbutazone in biological fluids and tissues. 2. Phenylbutazone is rapidly and… Expand
1953
1953
There have been several reports in the literature recently concerning the beneficial effects of phenylbutazone (butazolidin®) in… Expand
1953
1953
Extensive clinical trial has shown that phenylbutazone (Butazolidin) is effective in relieving pain and stiffness in such… Expand
1953
1953
Clinical trials oftwodrugs newtotheAmerican continent, phenylbutazone (Butazolidin) andbutapyrin, werebegunwiththeassumption… Expand
Highly Cited
1952
Highly Cited
1952
Phenylbutazone (butazolidin®) is one of a group of pyrazole derivatives developed by the chemists of the J. R. Geigy Co., of… Expand
1952
1952
Studies in Europe on parenteral use of aminopyrine necessitated the development of a solvent, and a pyrazol synthetic derivative… Expand